Fluent shares surge 11.95% intraday as regulated cannabis product availability and production innovations drive optimism.

Fluent surged 11.95% intraday trading following news highlighting its commitment to cannabis innovation and quality production. The article emphasized Fluent’s meticulous production standards, from nursery to lab, and its role in serving Florida medical marijuana patients with regulated THC/CBD products. This reinforces the company’s market position in the growing cannabis sector, aligning with positive investor sentiment. The second news item, involving a personal narrative with age-restricted content, is unrelated to the company’s operations and financial performance.